Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 898

1.

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.

Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH.

Soc Sci Med. 2005 Apr;60(7):1571-82.

PMID:
15652688
2.

Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?

Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, Brazier JE, Fortin PR, Anis AH.

Qual Life Res. 2005 Jun;14(5):1333-44.

PMID:
16047508
3.

The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.

Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP.

J Rheumatol. 2008 Apr;35(4):592-602. Epub 2008 Feb 15. Review.

PMID:
18278841
4.

A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.

Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):661-71. Epub 2011 Aug 31.

PMID:
21813061
5.

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.

Harrison MJ, Lunt M, Verstappen SM, Watson KD, Bansback NJ, Symmons DP.

Health Qual Life Outcomes. 2010 Feb 11;8:21. doi: 10.1186/1477-7525-8-21.

6.

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis.

Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A, Anis AH.

Med Care. 2004 Nov;42(11):1125-31.

PMID:
15586840
7.

Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.

Lillegraven S, Kristiansen IS, Kvien TK.

Ann Rheum Dis. 2010 Oct;69(10):1762-7. doi: 10.1136/ard.2009.124099. Epub 2010 May 6.

PMID:
20448285
8.

The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment.

Marra CA, Lynd LD, Esdaile JM, Kopec J, Anis AH.

Rheumatology (Oxford). 2004 Nov;43(11):1390-7. Epub 2004 Aug 3.

9.

A review of the psychometric properties of generic utility measures in multiple sclerosis.

Kuspinar A, Mayo NE.

Pharmacoeconomics. 2014 Aug;32(8):759-73. doi: 10.1007/s40273-014-0167-5. Review.

PMID:
24846760
10.

Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.

Ariza-Ariza R, Hernández-Cruz B, Carmona L, Dolores Ruiz-Montesinos M, Ballina J, Navarro-Sarabia F; Costs and Quality of Life in Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2006 Oct 15;55(5):751-6.

11.

Measuring disability and quality of life in established rheumatoid arthritis.

Lillegraven S, Kvien TK.

Best Pract Res Clin Rheumatol. 2007 Oct;21(5):827-40. Review.

PMID:
17870030
12.

A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.

McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, Ruggeri M, Giessler A, Puschner B, Thornicroft G.

J Ment Health Policy Econ. 2009 Mar;12(1):27-31.

PMID:
19346564
13.

Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.

Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T, Brazier J.

Arthritis Rheum. 2007 Aug 15;57(6):963-71.

14.
15.
16.
17.

Responsiveness of generic health-related quality of life measures in stroke.

Pickard AS, Johnson JA, Feeny DH.

Qual Life Res. 2005 Feb;14(1):207-19.

PMID:
15789955
18.

A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.

Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J.

J Rheumatol. 2003 Oct;30(10):2268-74.

PMID:
14528528
19.

Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

Walters SJ, Brazier JE.

Qual Life Res. 2005 Aug;14(6):1523-32. Review.

PMID:
16110932
20.

Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.

J Rheumatol. 2011 Aug;38(8):1576-84. doi: 10.3899/jrheum.101006. Epub 2011 May 1.

PMID:
21532054
Items per page

Supplemental Content

Write to the Help Desk